International Department

Amidst the ongoing advancements of modern medicine, oncology treatment is evolving towards greater precision, minimal invasiveness, and enhanced patient-centered care. At the Hyperthermia/HIFU Center of Beijing South Region Oncology Hospital, a warm “beam of light” known as “HIF...Read more »

“Doctor, my father is 81 years old. Can he still be treated?” – This brief sentence encapsulates the helplessness, anxiety, and deepest hopes of countless families when facing a serious illness in an elderly loved one. At the Beijing South Region Oncology Hospital International Depart...Read more »

On December 26, 2025, China’s National Medical Products Administration officially included the Boron Neutron Capture Therapy (BNCT) system in the priority review and approval process, marking the beginning of a “golden acceleration period” for this innovative technology in China...Read more »

At the beginning of 2026, China’s oncology treatment field has achieved a major breakthrough. On January 5, the China National Medical Products Administration (NMPA) officially approved the new-generation targeted drug Repotrectinib for the treatment of adult patients with solid tumors harboring ...Read more »

Recently, China’s National Medical Products Administration (NMPA) approved Enhertu for injection for the treatment of specific types of patients with advanced breast cancer, marking a significant advancement in the global fight against breast cancer. This approval is based on the positive r...Read more »

On December 15, 2025, China’s National Medical Products Administration officially approved the market launch of the new anti-cancer drug zurletrectinib (ICP-723). This milestone breakthrough brings unprecedented therapeutic hope to patients worldwide with solid tumors harboring NTRK fusion ...Read more »

On December 24, 2025, China’s National Medical Products Administration (NMPA) approved a significant new tumor treatment technology—the domestically developed Tumor Treating Fields (TTFields) device officially entered the market. This product marks a major breakthrough for China in the field of h...Read more »

Beijing, September 5, 2025 – In the advanced Hyperthermia/HIFU Treatment Center of the Beijing South Region Oncology Hospital International Department, two hopes from different countries and backgrounds were gently illuminated on the same day. **Healing Across Borders: A Heartwarming Story from M...Read more »

  In the Hyperthermia/HIFU (commonly known as “Hyperthermia/HIFU”) room at Beijing South Region Oncology Hospital, a special treatment session had just concluded. Alex (pseudonym), a patient with liver metastasis from abroad, slowly regained consciousness. He instinctively touche...Read more »

On the long and arduous journey of fighting cancer, many patients endure a series of challenging processes such as surgery, chemotherapy, and targeted therapy. When the disease recurs and treatment outcomes fall short of expectations, it is inevitable to feel lost and weary. However, medical adva...Read more »

In oncology, pancreatic cancer is often termed the “king of cancers” due to its aggressive nature and poor prognosis. When it metastasizes to the liver, treatment options become severely limited, with surgical opportunities rare. Patients endure severe pain and often face despair. Yet...Read more »

When facing a cancer diagnosis, patients and their families yearn most for a treatment that is both effective and minimally taxing on the body. Today, a revolutionary tumor treatment technology from China—the Combined Cryo-thermal Ablation—is providing new hope and options for international patie...Read more »